Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Massachusetts' largest commercial health insurer is rolling back its coverage of GLP-1 drugs like Ozempic and Wegovy for ...

Explore the benefits of Mochi Health, a telehealth platform offering personalized weight loss solutions and support.

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Novo ...

Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their GLP-1 products. Lilly markets its dual GIP and GLP-1 receptor agonist, ...

Pincus Plastic Surgery Dr. David Pincus, Pincus Plastic Surgery SMITHTOWN, NY, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- The rise of weight-loss medications ...

SMITHTOWN, NY, UNITED STATES, April 4, 2025 /EINPresswire / -- The rise of weight-loss medications like Ozempic, Wegovy, and Mounjaro has transformed bodies-and unexpectedly, faces. As thousands ...

Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs known as GLP-1 agonists used to treat people with type 2 diabetes. While some GLP-1 agonists are used for weight loss in people ...

So, then I kind of blamed Ozempic.” Elon Musk said his drastic weight loss was due to “fasting” and “Wegovy.” Getty Images Elon Musk admitted to using Wegovy, an injection used for ...